Category Archives: C Diff Foundation

Nick Van Hise, PharmD, BCPS Is Welcomed As Chair Of the C Diff Foundation’s Antimicrobial Stewardship and C.diff. Infection Prevention (ASCP) Committee


We are honored to have Nick Van Hise, PharmD, BCPS  Chair the C Diff Foundation’s Antimicrobial Stewardship and C. diff. Infection Prevention (ASCP) Committee and promote the Foundation’s mission worldwide.

 

Nick Van Hise, PharmD, received a Bachelor of Science from Bradley University in Peoria, IL and his Doctorate of Pharmacy from Union University School of Pharmacy in Jackson, TN.

Dr. Van Hise then went on to do an infectious disease residency and become board certified in pharmacoltherapy and infectious disease.  Dr. Van Hise has been published in various scientific journals, includng the New England Journal of Medicine, Clinical Infectious Diseases, and the Journal of Clinical Neuropharmacology.

In addition, Dr. Van Hise is a Member of the Society of Infectious Diseases Pharmacists (SIDP), American Association of Pharmaceutical Scientists (AAPS), and American Pharmacists Association (APhA).

CutisPharma Partners With C Diff Foundation To Support C.difficile Infection Awareness and Advocacy Efforts

 

CutisPharma and the C Diff Foundation announced the launch of a partnership beginning on November 1, 2017, the first day of Clostridium difficile awareness month.  As part of the partnership, CutisPharma awarded an unrestricted grant to the Foundation to further support its awareness efforts.

“We are pleased to partner with the C Diff Foundation and support its education and advocacy efforts benefiting patients impacted by Clostridium difficile Infection,” said Neal I. Muni, MD, MSPH, Chief Executive Officer of CutisPharma.  “It’s our hope that our work together can make positive strides in building awareness of this life-threatening condition that affects over a half-million patients in the United States annually.”

The nonprofit C Diff Foundation is dedicated to supporting global public health initiatives for Clostridium difficile Infection (CDI), also called C. difficile or C. diff – for infection prevention, treatments and environmental safety.

“We are very thankful for CutisPharma’s support of our foundation’s efforts,” said Nancy Caralla, Foundress and Executive Director of the C Diff Foundation, who is both a nurse and a three-time C. difficile survivor who also lost her father to a C. difficile infection.  “CutisPharma’s mission to improve the lives of patients with unmet medical needs is aligned with our foundation’s goals, and we look forward to partnering with Neal and his team to further our education and advocacy efforts on behalf of patients and survivors.”

CutisPharma has undertaken several initiatives to expand from its traditional base of making compounding kits for pharmacists, including the development and commercialization of FDA-approved drugs. The filing of the Company’s first FDA New Drug Application earlier this year, by its RM Therapeutics subsidiary, was a key milestone in the Company’s expansion goals.

About CutisPharma

CutisPharma, Inc., based in Wilmington, Mass., is a privately held, specialty pharmaceutical company that has historically developed and distributed kits used by pharmacists to safely create compounded medications for nearly 20 years.  The Company’s products include oral solutions and suspensions, such as antimicrobials, mouthwashes, and PPIs; topicals, including hydrocortisone; and suppositories, including progesterone VGS.  CutisPharma’s FIRST Unit-of-Use Kits have benefited millions of patients who are unable to swallow conventional oral dosage forms such as tablets and capsules and whose needs are not served by commercially available therapies.  For more information, visit www.cutispharma.com.

Thanksgiving Reflections With Gratitude – 2017

Dear Members, Followers, and Visitors,

It’s hard to believe another  year has caught up with us and here we are preparing for the Thanksgiving holiday and reflecting upon the days that have passed by in 2017.

 

During this year we have been expanding across  the globe and reaching far away lands
meeting great people like you who are devoted to “Promoting C. diff. Awareness” with
the C Diff Foundation.

worldaround

We want to extend our gratitude to you and everyone for the warm welcome this past
year.  In our travels, and communication we get to discover many organizations doing outstanding work.

Each organization dedicated in researching and developing new avenues to prevent and treat a Clostridium difficile infection are all successful, appreciated, and applauded by the patients and their families who are being treated and recovering from a          C. difficile infection.

The C Diff Foundation is an exceptional organization, and its special ingredients
are what makes us so proud to be a part. The first of these is our outreach programs. We offer patients and their families opportunities worldwide to gain support and information which is vital during a C. diff. infection and during the recovery phase of this infection.

The second special ingredient is the dedicated volunteering staff here in the USA,  most of whom have been faithfully serving our Foundation since the formation in 2012.

The third special ingredient is you and all the Volunteer Advocates worldwide with the financial supporters who see to it that our mission continues promoting  “C. difficile Awareness” with the many programs in place to make you and your communities stronger than ever in C. diff. infection prevention, treatment information, support, and environmental safety products available.

CDiffAwarenessRibbon2015

As we work together today and in the coming  year, seeking opportunities to bring hearts to a mend through the C. diff. Global Community Support Program, we look forward to speak with you by phone via: Teleconferencing sessions or in person at a local event.  Sessions are scheduled each month and available throughout the US and accessible from 57 countries right now.  Register through the website support page or call us (919) 201-1512 and register for upcoming sessions.  It will be our pleasure to speak with you about C. diff. infections, financial support, pharmaceutical information, group discussions related to anxiety and depression, nutrition, and sessions speaking with others that truly understand the diagnosis and ways to work through it.

We encourage you to introduce others to the C Diff Foundation and to the validated information provided.

As we come together with friends, family, and strangers~  let us reflect on our own thoughts and reflections of gratitude and let us light a candle to signify “hope” – the shining light that we see in the shadows when turmoil and struggles occur.

The days may becoming shorter during the winter months on the horizon but our light of “hope” for better health and stronger days has never shown brighter than today.

 

 

 

 

We especially wish to thank the many USA Governors for signing State Proclamations declaring “November Clostridium difficile Infection Awareness Month.”

The gratitude expressed by the patients and their families is overwhelming and the health care professionals around the globe hold this statement in the highest regards.

“We are thankful!”

We are all truly grateful for the opportunity to work with dedicated volunteers, healthcare professionals, scientific researchers, and associates from so many worthy organizations.

Thank you for all that you do for others, for their communities – and partnering with the C Diff Foundation in  our mission of educating and advocating for C. difficile infection prevention, treatments, environmental safety, and support worldwide!

Julio C. Guerra MD, FAAP Is Welcomed As a Member Of the C Diff Foundation’s Medical Advisory Board

We are honored to have
Julio C. Guerra, MD, FAAP join the C Diff  Foundation’s Medical Advisory Board as we continue to grow and promote the prevention, treatments, and environmental safety for C. difficile infections
and healthcare-associated infections worldwide.

 

Dr. Guerra is a seasoned healthcare professional with the ability to fuse clinical expertise and his passion for medical innovation. He is the founder and CEO of Itus Healthcare, a New Jersey Medical Device company and through a series of important research, product development and commercialization milestones, has led the Itus Healthcare team with the development of innovative products that address the prevention and control of Healthcare Associated Infections.

Dr. Guerra is the Founder and CEO, Itus Healthcare, LLC. Medical device company focused on innovative products for the prevention of Healthcare Associated Infections and
Present (1992 – present): Medical Director and Owner, College Plaza Pediatrics, PC, medium size pediatric ambulatory centers located in both Randolph and Hackettstown, New Jersey.

Education:
1987-1988: Albert Einstein College of Medicine, New York, New York. Fifth Pathway Clinical Clerkship Program
1983-1987: Universidad Autonoma de Guadalajara, Guadalajara, Mexico, Medical Degree
1977-1983: St. Mary’s University, San Antonio, Texas, Bachelor of Science in Biology / Minor in Chemistry.

Clinical Training:
1991-1992: Chief Resident, Overlook Hospital, Summit, New Jersey, Internal Medicine / Pediatrics Combined Residency Program
1988-1991: Internal Medicine / Pediatrics Combined Residency Program, Overlook Hospital, Summit, New Jersey

Academic Experience:
1993-1996: Director of Ambulatory Pediatrics, Overlook Hospital. Summit, New Jersey. Directed pediatric education program for both medical students and residents from Columbia University, New York City.

With a long line of innovative applications and designs, Dr. Guerra has accomplished developing the following:
2015 – Co-Inventor of StethGuard™ Disposable Stethoscope Covers
2014 – My Medical Inventory™ – Designed and developed a medical SAAS (Software As A Service) web based software program for inventory and tracking of inventory and medical practice optimization.
2012 – Smart Phone (iPhone / Android) Application. “Kids Weight” application. Medical application for converting pediatric weights from gms. / kgs. to pounds/ ounces.
2011 – Smart Phone (iPhone / Android) Application. “The Baby Scale” application. Application for calculating percentage of body weight loss during the newborn period to assist pediatric healthcare professionals with newborn nutrition management.
2011 – Smart Phone (iPhone / Android) Application. “The Kids Fever MD” application. Application for calculating correct dosing of acetaminophen and ibuprofen for professional pediatric healthcare providers and consumers.
1997 – “Survanta®” NICU Palm Pilot Dosing Calculator for neonatologists. Mathematical calculator that provides accurate dosing in aliquots and positions for preterm / term infants with RDS based on infants weight.
1992 – Newborn Visual Stimulation Designs. Award winning visual stimulation designs for newborn infants. Developed visual stimulation designs used all over the world to enhance visual tracking in preterm and newborn infants. Designs licensed by Ross Labs® makers of Similac® from 1992-1995.

Volunteering is part of community team work that is no stranger to Dr. Guerra and we appreciate his time and support of the C Diff Foundation with the contributions he has made over the years with the following organizations:
2007: New York Marathon runner for the “Team for Kids”
2005: Foundation for Peace. Assisted this organization in providing formula and medical equipment for their programs in San Domingo
2004: Pediatrics AIDS work in Ethiopia, Africa
2001, September 11-13: 9/11 “First Responder” Physician at Ground Zero (World Trade Towers), New York, New York
1992-1994: Pediatric AIDS of Newark, New Jersey. Worked with children afflicted with AIDS and assisted with providing them physical exams for attending summer camps
1994-present: Developed fund drives for assisting various children with different life threatening diseases

Awards:
2017 – Randolph Township Business Achievement Award – Itus Healthcare
New Jersey Top Docs – 2010, 2011, 2012, 2013 Patient’s Choice Award – 2009, 2010, 2011,2012, 2013 Compassionate Doctor Award 2009, 2010, 2011,2012, 2013
New Jersey Favorite Kids Doc Award – 2009 – 2017
Best Doctors in America, 2005 – present

Medical Boards:
1994- Present: Diplomate of the American Board of Pediatrics
1994-Present: Fellow of the American Academy of Pediatrics
Medical License:
New Jersey
New York

Have You Been Treated For a C. diff. Infection? Take a Brief Survey To Help Improve Education for C.diff. Patients and Caretakers

 
The C.diff Foundation is working with a partner to conduct a survey about your experience with a C.diff. infection to help inform educational initiatives for C.diff patients and caretakers.

If you or someone you know has had a personal experience with a C.diff, infection please go to our website, www.cdifffoundation.org, and take the short survey.

Thank you for making a difference and shaping the future of C. diff. infection prevention education.

 

Norman B. Javitt, M.D. Is Welcomed As a Member Of the C Diff Foundation, R & D Committee

We are pleased to welcome
Norman B. Javitt, M.D. to the
C Diff Foundation.

Dr. Javitt has an extensive professional career in health care.  New York University Medical Center: Instructor, then Assistant Professor Medicine where his career was devoted mostly to research in liver disease, specifically in inborn errors of cholesterol metabolism affecting newborns, and to teaching medical students.

Cornell University Medical School-New York Hospital:  Associate Professor of Medicine, then Professor of medicine and Chief, Division of Gastroenterology the research program continued to grow, attracting many fellows from all over the world.  Also provided care for private patients, both children and adults, with difficult liver problems.

New York University Medical Center:  Professor of Medicine and of Pediatrics, Division chairman Hepatic Diseases April, Research professor 2015-presnt.  At NYUMC Dr. Javitt has been focusing on C. difficile research  and teaching medical students and house staff.  His research interest has also expand to many areas of cholesterol synthesis and metabolism other than just liver disease.

Dr. Javitt has published research papers in age-related macular degeneration, in vitro fertilization, and Alzheimer’s disease.  He has also published more than 150 research papers, in addition to several books and review articles, and presented work at numerous professional meetings and symposia throughout the world.  His work has been supported by the National Institutes of Health, by private foundations and Pharmaceutical companies.  Dr. Javitt is welcomed by fellow researchers in the Research and Development Committee Chaired by Professor Simon M. Cutting, Ph.D…

C. diff. Spores and More, Join Us and Celebrate

www.cdiffradio.com

C. diff. Spores and More

Sponsored by Clorox Healthcare

Join us and Celebrate

with our 81,453 listeners – so far –  in Season III.

We thank our listeners joining us every

Tuesday at 10:00 a.m. PT / 1:00 p.m. ET

across the U.S. A. and to our listeners in

  • Australia
  • Brazil
  • Canada
  • China
  • France
  • Germany
  • India
  • Ireland
  • Israel
  • Japan
  • Malaysia
  • Peru
  • Russia
  • Spain
  • Switzerland
  • Taiwan
  • Trinidad
  • Ukraine
  • UK    and Across the Globe

We also extend our sincere gratitude to the guests who take time out of their busy

schedules to join us on each live broadcast.  Though their words of wisdom and

by sharing the most up-to-date information with us raises awareness in so

many important areas of healthcare.

 

Season III concludes on October 31, 2017

and we will be gearing up for

the 5th Annual International C. diff. Awareness Conference & Health EXPO taking

place on November 9th and 10th at the University of Nevada – Las Vegas.

For conference information please click on the link below.

https://cdifffoundation.org/2017cdiffconference/about-nov-2017-annual-conference/

 

Join us in Season IV when we return on January 9th, 2018

as we continue bringing you updates that are focused on, but not limited to,

C. difficile infection prevention, treatments, clinical trials, environmental safety

and much more.

Thank you again for listening and we wish you and your families improved health,

continued healing, and the best day — which you all deserve!